Constrained compounds as CGRP-receptor antagonists
    2.
    发明授权
    Constrained compounds as CGRP-receptor antagonists 有权
    约束化合物作为CGRP受体拮抗剂

    公开(公告)号:US07384931B2

    公开(公告)日:2008-06-10

    申请号:US11417326

    申请日:2006-05-03

    CPC分类号: C07D471/04 C07D487/04

    摘要: The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors

    摘要翻译: 本发明包括受限制的双环和三环CGRP受体拮抗剂,鉴定它们的方法,包含它们的药物组合物及其用于治疗偏头痛和其他头痛,神经源性血管舒张,神经源性炎症,热损伤,循环休克,冲洗的方法 与更年期,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)有关的其他病症,其治疗可以通过CGRP受体的拮抗作用

    Constrained compounds as CGRP-receptor antagonists
    3.
    发明授权
    Constrained compounds as CGRP-receptor antagonists 有权
    约束化合物作为CGRP受体拮抗剂

    公开(公告)号:US07544680B2

    公开(公告)日:2009-06-09

    申请号:US12105434

    申请日:2008-04-18

    CPC分类号: C07D487/04

    摘要: The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

    摘要翻译: 本发明包括受限制的双环和三环CGRP受体拮抗剂,鉴定它们的方法,包含它们的药物组合物及其用于治疗偏头痛和其他头痛,神经源性血管舒张,神经源性炎症,热损伤,循环休克,冲洗的方法 与更年期,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)相关的其它病症以及其治疗可以通过CGRP受体的拮抗作用来实现。

    Constrained Compounds as CGRP-Receptor Antagonists
    4.
    发明申请
    Constrained Compounds as CGRP-Receptor Antagonists 有权
    约束化合物作为CGRP受体拮抗剂

    公开(公告)号:US20080287422A1

    公开(公告)日:2008-11-20

    申请号:US12105434

    申请日:2008-04-18

    CPC分类号: C07D487/04

    摘要: The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

    摘要翻译: 本发明包括受限制的双环和三环CGRP受体拮抗剂,鉴定它们的方法,包含它们的药物组合物及其用于治疗偏头痛和其他头痛,神经源性血管舒张,神经源性炎症,热损伤,循环休克,冲洗的方法 与更年期,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)相关的其它病症以及其治疗可以通过CGRP受体的拮抗作用来实现。

    CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS
    6.
    发明申请
    CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS 有权
    受约束的化合物作为CGRP受体拮抗剂

    公开(公告)号:US20070259850A1

    公开(公告)日:2007-11-08

    申请号:US11742615

    申请日:2007-05-01

    CPC分类号: C07D491/04 C07D487/04

    摘要: The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

    摘要翻译: 本发明包括受限制的双环和三环CGRP受体拮抗剂,鉴定它们的方法,包含它们的药物组合物及其用于治疗偏头痛和其他头痛,神经源性血管舒张,神经源性炎症,热损伤,循环休克,冲洗的方法 与更年期,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)相关的其它病症以及其治疗可以通过CGRP受体的拮抗作用来实现。

    Therapeutic agents for the treatment of migraine
    10.
    发明授权
    Therapeutic agents for the treatment of migraine 有权
    用于治疗偏头痛的治疗剂

    公开(公告)号:US07772244B2

    公开(公告)日:2010-08-10

    申请号:US11091429

    申请日:2005-03-28

    CPC分类号: C07D401/14

    摘要: The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

    摘要翻译: 本发明涉及作为降钙素基因相关肽受体(“CGRP受体”)拮抗剂的式(I)化合物,包含它们的药物组合物,鉴定它们的方法,使用它们的治疗方法及其在治疗治疗中的用途 神经源性血管舒张,神经源性炎症,偏头痛和其他头痛,热损伤,循环休克,与更年期相关的潮红,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)以及其他治疗可以通过 CGRP受体的拮抗作用。